NEW YORK, GenomeWeb News (March 30) - IBM and Affymetrix will collaborate to integrate genomic research data and patient information, the companies said today.
Affymetrix and IBM plan to combine open standards technologies, including Affymetrix's GeneChip technology and IBM's services in regulatory compliance, business integration, and systems integration, to create a system that will allow researchers to cross-reference genomic data with patient data.
In their collaboration, IBM and Affymetrix plan to work with research organizations and institutes, pharmaceutical companies, and other organizations.
The H. Lee Moffitt Cancer Center and Research Institute at the University of South Florida will collaborate with the two companies to design clinical trials that take into account genetic research.